Benitec Biopharma Ltd () is an Australian
biotechnology company
Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used by ...
founded in 1997.
It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using
DNA-directed RNA interference (ddRNAi) technology.
The
Commonwealth Scientific and Industrial Research Organisation (CSIRO) has researched RNAi extensively, developing the
small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research.
Research and development
Benitec Biopharma is researching
ddRNAi in the following fields:
*
Hepatitis B (under development with partner Biomics Biotechnologies)
)
*
Oculopharyngeal muscular dystrophy (OPMD)
References
{{reflist, colwidth=30em
External links
Benitec Biopharma website
Biotechnology companies of Australia
Stem cells
Biopharmaceutical companies
Genetic engineering
Companies based in Sydney
Multinational companies headquartered in Australia
Biotechnology companies established in 1997
Companies listed on the Nasdaq
Companies formerly listed on the Australian Securities Exchange
Australian brands
Pharmaceutical companies established in 1997
Australian companies established in 1997
Science and technology in Melbourne